Glycoprotein nonmetastatic melanoma protein B ameliorates skeletal muscle lesions in a SOD1G93A mouse model of amyotrophic lateral sclerosis
Authors:
- 3 July 2015
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 93 (10) , 1552-1566
Abstract
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive loss of motor neurons and subsequent muscular atrophy. The quality of life of patients with ALS is significantly improved by ameliorating muscular symptoms. We previously reported that glycoprotein nonmetastatic melanoma protein B (GPNMB; osteoactivin) might serve as a target for ALS therapy. In the present study, superoxide dismutase 1/glycine residue 93 changed to alanine (SOD1G93A) transgenic mice were used as a model of ALS. Expression of the C‐terminal fragment of GPNMB was increased in the skeletal muscles of SOD1G93A mice and patients with sporadic ALS. SOD1G93A/GPNMB transgenic mice were generated to determine whether GPNMB expression ameliorates muscular symptoms. The weight and cross‐sectional area of the gastrocnemius muscle, number and cross‐sectional area of myofibers, and denervation of neuromuscular junctions were ameliorated in SOD1G93A/GPNMB vs. SOD1G93A mice. Furthermore, direct injection of a GPNMB expression plasmid into the gastrocnemius muscle of SOD1G93A mice increased the numbers of myofibers and prevented myofiber atrophy. These findings suggest that GPNMB directly affects skeletal muscle and prevents muscular pathology in SOD1G93A mice and may therefore serve as a target for therapy of ALS.Keywords
Funding Information
- grants from the Ministry of Education
- Grant-in-Aid for Scientific Research (25460103)
This publication has 60 references indexed in Scilit:
- Neuromuscular effects of G93A-SOD1 expression in zebrafishMolecular Neurodegeneration, 2012
- The potential of GPNMB as novel neuroprotective factor in amyotrophic lateral sclerosisScientific Reports, 2012
- Elevated PGC-1α Activity Sustains Mitochondrial Biogenesis and Muscle Function without Extending Survival in a Mouse Model of Inherited ALSCell Metabolism, 2012
- Mutant TDP-43 in motor neurons promotes the onset and progression of ALS in ratsJournal of Clinical Investigation, 2012
- Myocardial transfection with naked DNA plasmid encoding hepatocyte growth factor prevents the progression of heart failure in dogsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic miceHuman Molecular Genetics, 2010
- Glycoprotein nonmetastatic melanoma protein b, a melanocytic cell marker, is a melanosome‐specific and proteolytically released proteinThe FASEB Journal, 2010
- The DC‐HIL/syndecan‐4 pathway inhibits human allogeneic T‐cell responsesEuropean Journal of Immunology, 2009
- Amyotrophic lateral sclerosisOrphanet Journal of Rare Diseases, 2009
- PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3Nature Medicine, 2004